Ira Haimowitz

ZS Data Strategy Life Science Industry Study results are out! Over the past decade, the global healthcare #data landscape has evolved at an unprecedented pace. #lifescience organizations are increasingly recognizing data as a vital enabler of corporate value. But with this evolution comes a set of critical questions for #datastrategy leaders: - How are life science organizations adapting to these changes?  - What are industry best practices for data strategy? - Which business models, data providers, and technologies are gaining traction? To shed some light on these key questions, ZS Associates conducted the Data Strategy Life Science Industry Survey, engaging with data strategy leaders from 38 global life science companies—covering 80% of the top 20 organizations by global revenue. This whitepaper, co-written with Filippo Cellini, PhD, Waldemar Ockert, PhD, and Merwin Lau, explores the key findings of the study, including maturity levels and the evolution of the data strategy function within the life science industry. Enjoy and let us know your thoughts! #lifesciences #pharmaceuticals #medtech #Healthcaredata #ZS #datastrategy

120

4 Comments

Learn how life sciences and healthcare organizations can create healthier tomorrows by leveraging real-world evidence and real-world data differently. #ImWithSlalom https://slalom.ws/3xYlIyz

2

Thanks to Robert Connley for sharing insights on the impact of #Pega in driving ROI of Digital Health Interventions at our EY #DigitalHealthontheHill panel. Great discussion on leveraging technology and AI to enhance healthcare outcomes! #DigitalHealth #ROI #EYPega

20

Another great insight from Metyis! 🚀 Insights with Marcello Cacciato: Metyis Data Science Director breaks down GenAI’s real-world impact 💡 The benefits of GenAI for business  ✅ Boosted customer interaction ✅ Streamlined operations   ✅ Unleashed creativity https://lnkd.in/dUYAMYWU #wearemetyis #partnersforimpact

18

Disruption mode on! Exciting times to be in AI and Fintech. As a consumer - I can’t wait to see what all this investment will yield! Especially when it comes to saving my time and money. As a professional - let’s go and make history defining the next-generation of products and delightful experiences our customers will love! #aiproductmanagement #letsgo!

21

ZS experts offer a step-by-step guide to team design—from vision to compliance—with tips to set these key players up for success. https://bit.ly/3TGfhrz #FutureCommercialModel

2

Learn how life sciences and healthcare organizations can create healthier tomorrows by leveraging real-world evidence and real-world data differently. #ImWithSlalom https://slalom.ws/3S7hWtm

1

In our latest Pulse of Change survey, we polled 2,800 C-suite executives across 18 countries to see if GenAI is living up to the hype. Here are a few key takeaways: - Almost 100% of C-suite leaders acknowledge Gen AI's influence on customer acquisition and retention. - 65% see the technology as a key driver for revenue growth, and 35% recognize its impact on cost reduction. - 54% of leaders have already integrated Gen AI into their customer strategies, enhancing services with chatbots that offer real-time, personalized interactions. - 49% of C-suite leaders report that their Gen AI investments are outperforming other technologies. To make the survey user-friendly, we’ve made it searchable by industry, geography or role. You can access the Pulse of Change survey here: https://lnkd.in/e478hJ_X  #GenAI #PulseOfChange #BusinessStrategy #Csuite Jack Azagury, Karalee Close, Michael Benyamin, Elena Pienkowski

118

1 Comment

The future of life sciences CRM is changing: Veeva is out, Salesforce is in. Discover five key actions to future-proof your CRM strategy in this article by Slalom's Brian Moy. #ImWithSlalom #SlalomLifeSciences https://slalom.ws/3AL0mpd

8

My perspective on value-driven scalable generative AI programs to gain a multi-year competitive advantage for BioPharma. Cognizant Bryan Hill Archana Ramanakumar Gaurav Marya Rohit Alimchandani Gagan Syal Josh Voluck Vivek Gupta Kumar Ramananda Yatin Patki Vinamra (Vin) Singhania Ritesh Ranjan Manish Sakhuja Darpan Ahuja

42

2 Comments

Curious about how AI is reshaping the landscape? Dive into our latest article on #PCAOB observations and #JGA's perspective on GenAI. Discover key insights and future trends shaping the industry. https://ow.ly/ZS6n50SQQ0V #AI #PCAOB #GenAI

2

Advances in digital and AI have forced pharma companies to ask: “Where can digital and AI take the lead, and where are reps truly irreplaceable?” On Nov. 12, ZS’s Namita Powers will present research on the key moments where sales reps deliver unmatched value. Register here. https://bit.ly/4hLDI0Y

5

I am honored to be presenting tomorrow to CHIEF, the largest network of senior women executives, on the topic of AI Governance, in a webinar titled, "Enterprise AI Governance: A Cross-Functional Approach for Executives." If you are a CHIEF member, please join me! #AIGov #AIGovernance #AIRisk

40

In this timely piece, KPMG US Joe Zaccaria and Lindsey Manning explore the rising importance of real-world data (RWD) in healthcare and life sciences organizations. Early adopters are addressing the emergence of Generative AI models, complex clinical development programs, the shift toward value-based delivery, and FDA guidance to foster innovation, establish industry partnerships, and enhance patient-centered care. #RealWorldData #KPMGLifeSciences #HealthcareInnovation #GenAI #KPMGDeals https://bit.ly/3YfwDhR

2

Closing the gap between people and technology in healthcare is now possible. Accenture's Rich Birhanzel shares three key challenges and insights on the importance of responsible AI in humanizing healthcare. #AIinHealthcare #FutureofHealthcare

27

Meet with ZS at #InformaticaWorld24 to learn how we are enhancing enterprise data management and leveraging gen AI. Book a meeting here: https://bit.ly/3Ub3x0P #datagovernance #datamanagement #artificialintelligence #AI

4

In today's rapidly changing world, building resilience is crucial for success in the #MedTech industry. Check out this insightful blog from Accenture’s Tom Kawalec on how MedTech companies can navigate disruptions, optimize operations, and capture market share: https://accntu.re/3xJnZNn

9